Share Success: Letters From Readers
I: From Sally
Submit Form Friday, July 28, 2017 at 16:07:51
Hi, my name is Sally. I am 84 years old, and have reached the age where my gait was becoming rather wobbly. In so much I had to hold someone's arm to keep steady.
I have been taking Ezorb for 6 weeks, and anxiously waiting for some of the results others had spoken about. Yesterday for the first time I noticed my walking was a lot steadier, (evidently I wasn't the first to notice this). I truly felt so much stronger And was walking faster and with so much more control.
I had read some very negative comments about it on another e-mal site and was really afraid to give it a try. I told myself "what if it didn't work" then the spirit said to me "yes, but what if it does??". Decided to listen to my spirit.
Thank you so much for the fast delivery, ( 5 days to Canada!)
II: From James K. North Bay, Ontario
Submit Form Sunday, May 28, 2017 at 19:59:58
Hi, my name is James K. I have been taking Marvlix for over ten years. It extended my life over ten years. That I know for sure.
My life style was not the best and this is the best way to say to thank you. God bless you all!
North Bay, ON Canada
III: From Lorraine W.
at Customer Service Feb 18 at 2:57 PM
Hi, my name is Lorraine W. I have been taking ezorb for bone spurs in my heel and my thumb.
After 6 months they are gone. I am going to keep taking it because as a bonus my hair got thick again like I was in my 20's and I am 75.
I wish I could send a picture of my thick hair half way down my back. But I don't see how to send it.
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. If your testimonial is selected for publication, you will receive a generous gift to show
our appreciation of your effort.
Research News: Gastric Bypass Effective In Diabetes Prevention
Research shows that patients who undergo Roux-en-Y gastric bypass are extremely unlikely to develop diabetes over the following decade, and a large proportion of those who have the condition at the time of surgery achieve remission.
The findings also suggest that earlier intervention – before patients become too dependent on medications for glycemic control - increases the chances of achieving diabetes remission.
In the observational study, published in The New England Journal of Medicine, the researchers found that just 3% of 303 patients who underwent Roux-en-Y gastric bypass developed diabetes during the subsequent 12 years, compared with 26% of 164 obese patients who had not undergone surgery (mostly because of health insurance issues) and 26% of 184 obese patients identified in the community.
Among the 88 surgery patients who had diabetes at baseline, remission rates were 75% at 2 years, 62% at 6 years, and 51% at 12 years. Among those who achieved 2-year remission, 69% remained in remission at 12 years.
The researchers note that diabetes remission rates reported in other studies with long-term follow-up, such as the Swedish Obese Subjects (SOS) study, are lower than achieved in their patients.
"These longer-term differences in remission between the two studies may be attributable to the exclusive use of the Roux-en-Y gastric bypass procedure in our study as compared with the primary use of vertical banded gastroplasty and the limited use of Roux-en-Y gastric bypass in the SOS study," they suggest.
The likelihood of diabetes remission at 12 years was strongly linked to patients' diabetes medications at the time of surgery; remission occurred in 73% of those who were not taking antidiabetic medications at the time of surgery, falling to 56% of those who were taking oral antidiabetics and 16% of those taking insulin.
"Thus, it is intuitive to suggest that the more advanced the type 2 diabetes, the less the glycemic benefit from Roux-en-Y gastric bypass," write Ted Adams (Intermountain Live Well Center Salt Lake, Utah, USA) and study co-authors.
They suggest that the markedly higher remission rates in patients not taking insulin is due "to the ability of partially viable beta cells to improve their function."
Patients who underwent surgery also had, on average, significant reductions in BMI and levels of glucose, low-density lipoprotein cholesterol, and triglycerides, along with a significant increase in high-density lipoprotein levels. They also achieved stable blood pressure and glycated hemoglobin, whereas these markers generally worsened in the nonsurgical groups.
As with diabetes, the incidence rates of hypertension and dyslipidemia were much lower, and the remission rates higher, in the surgery group relative to the nonsurgical patients.
Original research was published in 09-20-2017 | Metabolic surgery | News
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.